Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin

Subjects

Abstract

Acute and chronic pain (post-herpetic neuralgia or PHN) are encountered in patients with herpes zoster that is caused by reactivation of varicella-zoster virus (VZV) from a state of neuronal latency. PHN is often refractory to current treatments, and additional strategies for pain relief are needed. Here we exploited a rat footpad model of PHN to show that herpes simplex virus (HSV) vector-mediated gene delivery of human preproenkephalin (vHPPE) effectively reduced chronic VZV-induced nocifensive indicators of pain. VZV inoculated at the footpad induced prolonged mechanical allodynia and thermal hyperalgesia that did not develop in controls or with ultraviolet light-inactivated VZV. Subsequent footpad administration of vHPPE relieved VZV-induced pain behaviors in a dose-dependent manner for extended periods, and prophylactic vector administration prevented VZV-induced pain from developing. Short-term pain relief following low-dose vHPPE administration could be effectively prolonged by vector re-administration. HPPE transcripts were increased three- to fivefold in ipsilateral ganglia, but not in the contralateral dorsal root ganglia. VZV hypersensitivity and its relief by vHPPE were not affected by peripheral delivery of opioid receptor agonist or antagonist, suggesting that the efficacy was mediated at the ganglion and/or spinal cord level. These results support further development of ganglionic expression of enkephalin as a novel treatment for the pain associated with Zoster.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Leung J, Harpaz R, Molinari N A, Jumaan A, Zhou F . Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis 2011; 52: 332–340.

    Article  PubMed  Google Scholar 

  2. Harpaz R, Ortega-Sanchez IR, Seward JF . Advisory Committee on Immunization Practices Centers for Disease, C. & Prevention. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control 2008; 57: 1–30.

    Google Scholar 

  3. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271–2284.

    Article  CAS  PubMed  Google Scholar 

  4. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA . Neurological disease produced by varicella zoster virus reactivation without rash. Curr Top Microbiol Immunol 2010; 342: 243–253.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Haanpaa M, Laippala P, Nurmikko T . Pain and somatosensory dysfunction in acute herpes zoster. Clin J Pain 1999; 15: 78–84.

    Article  CAS  PubMed  Google Scholar 

  6. Kim SR, Khan F, Tyring SK . Varicella zoster: an update on current treatment options and future perspectives. Exp Opin Pharmacother 2014; 15: 61–71.

    Article  Google Scholar 

  7. Schmader K . Postherpetic neuralgia in immunocompetent elderly people. Vaccine 1998; 16: 1768–1770.

    Article  CAS  PubMed  Google Scholar 

  8. Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T . The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010; 8: 37.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Kinchington PR, Goins WF . Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models. J Neurovirol 2011; 17: 590–599.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Fleetwood-Walker SM, Quinn JP, Wallace C, Blackburn-Munro G, Kelly BG, Fiskerstrand CE et al. Behavioural changes in the rat following infection with varicella-zoster virus. J Gen Virol 1999; 80 (Pt 9): 2433–2436.

    Article  CAS  PubMed  Google Scholar 

  11. Garry EM et al. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 2005; 118: 97–111.

    Article  CAS  PubMed  Google Scholar 

  12. Hasnie FS, Breuer J, Parker S, Wallace V, Blackbeard J, Lever I et al. Further characterization of a rat model of varicella zoster virus-associated pain: relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience 2007; 144: 1495–1508.

    Article  CAS  PubMed  Google Scholar 

  13. Zhang GH, Lv MM, Wang S, Chen L, Qian NS, Tang Y et al. Spinal astrocytic activation is involved in a virally-induced rat model of neuropathic pain. PLoS One 2011; 6: e23059.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Dalziel RG, Bingham S, Sutton D, Grant D, Champion JM, Dennis SA et al. Allodynia in rats infected with varicella zoster virus—a small animal model for post-herpetic neuralgia. Brain Res Brain Res Rev 2004; 46: 234–242.

    Article  PubMed  Google Scholar 

  15. Zimmermann K . Science of Pain, by AI Basbaum and C Bushnell, 1st ed., Academic Press, 2009, 1088 pp., Reviewed by Katherine Zimmermann. Eur J Pain 2011; 15: 731

    Article  Google Scholar 

  16. Yaksh TL . Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol Scand 1997; 41: 94–111.

    Article  CAS  PubMed  Google Scholar 

  17. Mogil JS . Animal models of pain: progress and challenges. Nat Rev Neurosci 2009; 10: 283–294.

    Article  CAS  PubMed  Google Scholar 

  18. Takahashi M, Okuno Y, Otsuka T, Osame J, Takamizawa A . Development of a live attenuated varicella vaccine. Biken J 1975; 18: 25–33.

    CAS  PubMed  Google Scholar 

  19. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T . Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974; 2: 1288–1290.

    Article  CAS  PubMed  Google Scholar 

  20. Yokoyama H, Oguchi T, Goins WF, Goss JR, Nishizawa O, de Groat WC et al. Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception. Hum Gene Therapy 2013; 24: 170–180.

    Article  CAS  Google Scholar 

  21. Nagel MA, Gilden D . Complications of varicella zoster virus reactivation. Curr Treat Options Neurol 2013; 15: 439–453.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Gilden D, Nagel MA, Cohrs RJ, Mahalingam R . The variegate neurological manifestations of varicella zoster virus infection. Curr Neurol Neurosci Rep 2013; 13: 374.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Wilson SP, Yeomans DC, Bender MA, Lu Y, Goins WF, Glorioso JC et al. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci USA 1999; 96: 3211–3216.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Braz J, Beaufour C, Coutaux A, Epstein AL, Cesselin F, Hamon M et al. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J Neurosci 2001; 21: 7881–7888.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Lu Y, McNearney TA, Lin W, Wilson SP, Yeomans DC, Westlund KN . Treatment of inflamed pancreas with enkephalin encoding HSV-1 recombinant vector reduces inflammatory damage and behavioral sequelae. Mol Ther 2007; 15: 1812–1819.

    Article  CAS  PubMed  Google Scholar 

  26. Yeomans DC, Jones T, Laurito CE, Lu Y, Wilson SP . Reversal of ongoing thermal hyperalgesia in mice by a recombinant herpesvirus that encodes human preproenkephalin. Mol Ther 2004; 9: 24–29.

    Article  CAS  PubMed  Google Scholar 

  27. Yeomans DC, Lu Y, Laurito CE, Peters MC, Vota-Vellis G, Wilson SP et al. Recombinant herpes vector-mediated analgesia in a primate model of hyperalgesia. Mol Ther 2006; 13: 589–597.

    Article  CAS  PubMed  Google Scholar 

  28. Lu Y, McNearney TA, Wilson SP, Yeomans DC, Westlund KN . Joint capsule treatment with enkephalin-encoding HSV-1 recombinant vector reduces inflammatory damage and behavioural sequelae in rat CFA monoarthritis. Eur J Neurosci 2008; 27: 1153–1165.

    Article  PubMed  Google Scholar 

  29. Meunier A, Latrémolière A, Mauborgne A, Bourgoin S, Kayser V, Cesselin F et al. Attenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neurons. Mol Ther 2005; 11: 608–616.

    Article  CAS  PubMed  Google Scholar 

  30. Pinto M, Castro AR, Tshudy F, Wilson SP, Lima D, Tavares I . Opioids modulate pain facilitation from the dorsal reticular nucleus. Mol Cell Neurosci 2008; 39: 508–518.

    Article  CAS  PubMed  Google Scholar 

  31. Goss JR, Harley CF, Mata M, O’Malley ME, Goins WF, Hu X et al. Herpes vector-mediated expression of proenkephalin reduces bone cancer pain. Ann Neurol 2002; 52: 662–665.

    Article  CAS  PubMed  Google Scholar 

  32. Goss JR, Mata M, Goins WF, Wu HH, Glorioso JC, Fink DJ et al. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Therapy 2001; 8: 551–556.

    Article  CAS  PubMed  Google Scholar 

  33. Yokoyama H, Sasaki K, Franks ME, Goins WF, Goss JR, de Groat WC et al. Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Hum Gene Ther 2009; 20: 63–71.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Yoshimura N, Franks ME, Sasaki K, Goins WF, Goss J, Yokoyama T et al. Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE). Urology 2001; 57: 116.

    PubMed  Google Scholar 

  35. Hao S, Mata M, Goins W, Glorioso JC, Fink DJ . Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain. Pain 2003; 102: 135–142.

    Article  CAS  PubMed  Google Scholar 

  36. Yang H, McNearney TA, Chu R, Lu Y, Ren Y, Yeomans DC et al. Enkephalin-encoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model. Mol Pain 2008; 4: 8.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Hao S, Wolfe D, Glorioso JC, Mata M, Fink DJ . Effects of transgene-mediated endomorphin-2 in inflammatory pain. Eur J Pain 2009; 13: 380–386.

    Article  CAS  PubMed  Google Scholar 

  38. Zou W, Guo Q, Chen C, Yang Y, Wang E . Intrathecal herpes simplex virus type 1 amplicon vector-mediated human proenkephalin reduces chronic constriction injury-induced neuropathic pain in rats. Mol Med Rep 2011; 4: 529–533.

    CAS  PubMed  Google Scholar 

  39. Wolfe D, Hao S, Hu J, Srinivasan R, Goss J, Mata M et al. Engineering an endomorphin-2 gene for use in neuropathic pain therapy. Pain 2007; 133: 29–38.

    Article  PubMed  Google Scholar 

  40. Liu J, Wolfe D, Hao S, Huang S, Glorioso JC, Mata M et al. Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol Ther 2004; 10: 57–66.

    Article  CAS  PubMed  Google Scholar 

  41. Sun J, Liu S, Mata M, Fink DJ, Hao S . Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats. Gene Therapy 2012; 19: 101–108.

    Article  CAS  PubMed  Google Scholar 

  42. Huang W, Zheng W, Liu S, Zeng W, Levitt RC, Candiotti KA et al. HSV-mediated p55TNFSR reduces neuropathic pain induced by HIV gp120 in rats through CXCR4 activity. Gene Therapy 2014; 21: 328–336.

    Article  CAS  PubMed  Google Scholar 

  43. Hamza MA, Higgins DM, Ruyechan WT . Two alphaherpesvirus latency-associated gene products influence calcitonin gene-related peptide levels in rat trigeminal neurons. Neurobiol Dis 2007; 25: 553–560.

    Article  CAS  PubMed  Google Scholar 

  44. Kennedy PG, Montague P, Scott F, Grinfeld E, Ashrafi GH, Breuer J et al. Varicella-zoster viruses associated with post-herpetic neuralgia induce sodium current density increases in the ND7-23 Nav-1.8 neuroblastoma cell line. PLoS One 2013; 8: e51570.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Fink DJ, Wechuck J, Mata M, Glorioso JC, Goss J, Krisky D et al. Gene therapy for pain: results of a phase I clinical trial. Ann Neurol 2011; 70: 207–212.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Erazo A, Yee MB, Osterrieder N, Kinchington PR . Varicella-zoster virus open reading frame 66 protein kinase is required for efficient viral growth in primary human corneal stromal fibroblast cells. J Virol 2008; 82: 7653–7665.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Marconi P, Krisky D, Oligino T, Poliani PL, Ramakrishnan R, Goins WF et al. Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc Natl Acad Sci USA 1996; 93: 11319–11320.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Srinivasan R, Huang S, Chaudhry S, Sculptoreanu A, Krisky D, Cascio M et al. An HSV vector system for selection of ligand-gated ion channel modulators. Nat Methods 2007; 4: 733–739.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Dixon WJ . Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980; 20: 441–462.

    Article  CAS  PubMed  Google Scholar 

  50. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL . Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53: 55–63.

    Article  CAS  PubMed  Google Scholar 

  51. Hargreaves K, Dubner R, Brown F, Flores C, Joris J . A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77–88.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by National Institutes of Health Public Health Service grant NS064822 (to PRK), NS064988-02 (to JCG and WFG); a CORE grant for Vision Research (EY08098), training grants T32AI049820 and T32NS073548 (J-MGG); funds from the Eye and Ear Institute of Pittsburgh and the Research to Prevent Blindness Inc. We would also like to thank Drs Gerald Gebhart, Kathryn Albers, Fred Homa and James Goss for their insightful comments.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to W F Goins or P R Kinchington.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guedon, JM., Zhang, M., Glorioso, J. et al. Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin. Gene Ther 21, 694–702 (2014). https://doi.org/10.1038/gt.2014.43

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2014.43

This article is cited by

Search

Quick links